Enveda raises $311 million Series E to advance AI-discovered natural medicines
Enveda, the US biotech that uses AI to discover medicines from natural chemistry, has closed a $311 million Series E financing led by Catalio ...
Read the original at The Pharma Letter ↗
- Topics
- Markets & InvestmentBanking & Finance
- Tracked via
- “that uses AI to”